This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Larry King Cardiac Foundation And Quest Diagnostics Announce Partnership To Donate Diagnostic Testing To Patients In Need

In recognition of the devastating impact of cardiovascular disease and the financial barriers to life-saving care, the Larry King Cardiac Foundation and Quest Diagnostics (NYSE: DGX) today announced a partnership to help improve access to cardiac health care for individuals with heart disease. The partnership will enable the foundation to increase the number of individuals it can assist through advanced gene-based and routine diagnostics information services and access to life-saving treatment and care.

Through the LKCF/Quest Diagnostics partnership, Quest will donate advanced gene-based and routine testing services to patients identified and served by the LKCF to aid in the diagnosis and management of cardiovascular disease.

“We partner with premier cardiac care centers and hospitals around the country as part of our effort to ‘save a life a day.’ Now, with Quest Diagnostics’ participation, we can provide the testing that helps establish patient eligibility and course of treatment,” said Larry King, Founder of the LKCF. “It’s been a hallmark of the Larry King Cardiac Foundation to provide patients not only with access to life-saving cardiac care, but also with access to the highest quality and latest strides in medical care. I’m gratified that we’re able to bring the best and latest in diagnostic innovation from Quest Diagnostics to our participating doctors and patients around the country.”

According to the Centers for Disease Control and Prevention (CDC), about 600,000 people die of heart disease in the United States every year, with one death every 40 seconds. Heart disease is the leading cause of death for both men and women, and the leading killer of people of most ethnicities in the United States.

Medical care for heart disease can be expensive – in 2010, heart disease and stroke hospitalizations cost the nation more than $444 billion in health care expenses and lost productivity. Many people lack sufficient means to access critical medical attention for heart disease, with nearly one in five heart attack patients indicating that cost kept them from seeking health care, according to a 2007 study from Yale University. The Larry King Cardiac Foundation (LKCF) was established in 1988 after Mr. King’s 1987 successful quintuple bypass surgery following years of cardiovascular disease and, since the foundation’s inception, has helped thousands of individuals across the United States dealing with heart disease. The Foundation provides funding for life-saving treatment for individuals who would otherwise be unable to receive the treatment and care they need.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,141.82 +44.92 0.25%
S&P 500 2,099.71 +1.18 0.06%
NASDAQ 4,978.2450 +11.1040 0.22%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs